Solugen

Solugen is a Houston chemical manufacturer that combines engineered enzymes with metal catalysis to turn plant-derived sugar into chemicals used in oil and gas, water treatment, agriculture, cleaning, concrete and personal care. The company traces its start to 2016, when Gaurab Chakrabarti, then a PhD student at UT Southwestern, and Sean Hunt, a chemical engineering graduate student at MIT, met and decided to combine their disciplines. Chakrabarti is chief executive and Hunt is chief technology officer. The pair built a prototype reactor, entered the MIT entrepreneurship competition and went through Y Combinator in the Winter 2017 batch. Its headquarters and main research site sit on Minetta Street in Houston.

Solugen's own timeline sets out its financing. In 2018 it raised a $13.5 million Series A led by Fifty Years, Founders Fund and Y Combinator. In 2019 Founders Fund led a $32 million Series B with Y Combinator, Refactor Capital, Fifty Years and KdT Ventures. In 2021 GIC and Baillie Gifford led a Series C of more than $350 million, with Temasek, BlackRock, Carbon Direct Capital Management, Refactor Capital and Fifty Years participating. On October 31, 2022 the company announced a Series D of more than $200 million led by Kinnevik, Lowercarbon Capital and Refactor Capital, with Temasek, Baillie Gifford and Fifty Years returning; the release said the round lifted its valuation above $2 billion. The company now reports more than $640 million raised.

The money has gone into plants. Bioforge Houston, a 10,000-ton-per-year facility, came online in 2021. In 2023 Solugen announced a partnership with ADM to build a biomanufacturing facility next to ADM's corn complex in Marshall, Minnesota, and it broke ground there in April 2024. In June 2024 it received a conditional commitment for a $213.6 million loan guarantee from the Department of Energy's Loan Programs Office, and in November 2024 it was awarded a Department of Defense contract for bioindustrial manufacturing. At the time of the Series D the company said it ran a nearly nine-figure business with high margins. It lists more than 115 employees and sites in Houston, Slaton, Texas, and Marshall.

For investors, Solugen shows how a hard-tech company moves from seed money to growth rounds. Y Combinator, Founders Fund and Fifty Years backed it at the prototype stage and kept participating, while sovereign and crossover investors such as GIC, Temasek and Baillie Gifford came in once a commercial plant existed. The company also turned to government credit, which reduces how much equity it needs to build each new plant. It has no public listing or sale, so early backers' returns remain unrealized nearly a decade after founding.